Protocol EFC5555: Sub-Investigator, A Placebo controlled, Double-blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400mg bid for the Prevention of Cardiovascular Hospitalization or Death from any Cause in Patients with Atrial Fibrillation/At
Date:
August 20, 2012|Source:
No Source
